U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H21AsN8S2
Molecular Weight 428.411
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MELARSOMINE

SMILES

NCCS[As](SCCN)C1=CC=C(NC2=NC(N)=NC(N)=N2)C=C1

InChI

InChIKey=MGEOLZFMLHYCFZ-UHFFFAOYSA-N
InChI=1S/C13H21AsN8S2/c15-5-7-23-14(24-8-6-16)9-1-3-10(4-2-9)19-13-21-11(17)20-12(18)22-13/h1-4H,5-8,15-16H2,(H5,17,18,19,20,21,22)

HIDE SMILES / InChI

Molecular Formula C13H21AsN8S2
Molecular Weight 428.411
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Melarsomine (melarsomine dihydrochloride) is an organic arsenical chemotherapeutic agent and is a trypanocidal antiparasitic drug. As of 2016 DIROBAN, a generic melarsomine dihydrochloride product, is the only FDA-approved treatment for adult heartworm (Dirofilaria immitis) infection in dogs. It is not approved for treatment in cats, or dogs in late-stage infection. It is marketed by Merial under the trade name Immiticide and is not currently available in the U.S. due to a manufacturing shortage. Sponsored by Anzac Animal Health, LLC and distributed by Zoetis, Inc., DIROBAN is a prescription animal drug supplied as a sterile powder that must be reconstituted with an accompanying sterile water diluent. The exact mode of action on D. immitis is unknown. Post-treatment mortality due to thromboembolism and/or progression of the underlying disease may occur in 10 to 20% of the Class 3 patients treated with DIROBAN.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
DIROBAN

Approved Use

Treatment of stabilized, class 1, 2, and 3 heartworm disease (asymptomatic to mild, moderate, and severe, respectively) caused by immature (4 month-old, stage L5) to mature adult infections of Dirofilaria immitis in dogs.

Launch Date

2016
PubMed

PubMed

TitleDatePubMed
Heartworm and Wolbachia: therapeutic implications.
2008 Dec 10
Patents

Patents

Sample Use Guides

DIROBAN (sterile powder for injection contains 50.0 mg melarsomine dihydrochloride and 33.75 mg glycine USP; 1 vial: when reconstituted with 2 mL of sterile water for injection (provided) contains 25 mg/mL of active ingredient) should be administered by deep intramuscular injection ONLY in the epaxial (lumbar) muscles in the third through fifth lumbar region (see graphic). DO NOT ADMINISTER AT ANY OTHER SITE. Avoid superficial injection or leakage. Use a 23 gauge 1 inch needle for dogs equal to or less than 10 kg (22 lb) in weight. Use a 22 gauge 1½ inch needle for dogs greaterthan 10 kg (22 lb). Use alternating sides with each administration. If repeated administrations are warranted avoid injecting at the same lumbar location. Record the location of the first injection(s) in the patient’s medical record for future reference.
Route of Administration: Intravascular
In Vitro Use Guide
Isolated rings of pulmonary artery from heartworm-infected dogs were randomly treated with thiacetarsamide (30 ug/ml) or melarsomine dihydrochloride (30 ug/ml) for 30 minutes; untreated rings from the same dog served as control. Cumulative dose-response relations to norepinephrine, nitroglycerin, and methacholine were determined. Treatment of rings with thiacetarsamide or melarsomine depressed methacholine-induced relaxation, compared with values for untreated rings. Histologic examination of rings indicated that treatment with thiacetarsamide or melarsomine resulted in loss of endothelial cells.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:23:29 GMT 2023
Edited
by admin
on Fri Dec 15 16:23:29 GMT 2023
Record UNII
374GJ0S41A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MELARSOMINE
INN   MART.  
INN  
Official Name English
melarsomine [INN]
Common Name English
ARSONODITHIOUS ACID, AS-(4-((4,6-DIAMINO-1,3,5-TRIAZIN-2-YL)AMINO)PHENYL)-, BIS(2-AMINOETHYL) ESTER
Common Name English
MELARSAMIN
Common Name English
MELARSOMINE [MART.]
Common Name English
MELARSOMINE [MI]
Common Name English
BIS(2-AMINOETHYL) P-((4,6-DIAMINO-S-TRIAZIN-2-YL)AMINO)DITHIOBENZENEARSONITE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C250
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
WHO-VATC QP51AD06
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
Code System Code Type Description
CAS
128470-15-5
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
PUBCHEM
65962
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
NCI_THESAURUS
C66078
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
WIKIPEDIA
MELARSOMINE
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
SMS_ID
100000081445
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
FDA UNII
374GJ0S41A
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
RXCUI
1012534
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m12038
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
EPA CompTox
DTXSID40155907
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
DAILYMED
374GJ0S41A
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
INN
6676
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
EVMPD
SUB08719MIG
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
MESH
C076253
Created by admin on Fri Dec 15 16:23:29 GMT 2023 , Edited by admin on Fri Dec 15 16:23:29 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY